NUVBNuvation Bio Inc.

$5.00+55% 1Y

Is the price fair?

What NUVB's price assumes

Nuvation Bio Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 11.9× revenue.

11.9

Price / sales · no P/E: the last twelve months did not end in a profit

Price / book
7.97

Price / book · today's price, trailing year to Jun 30, 2026

EV / sales
9.48

EV / sales

Details›
Price / booktoday's price, trailing year to Jun 30, 2026
7.97
EV / EBIToperating margin −81%: the multiple describes the denominator
not meaningful
EV / salestoday's price, trailing year to Jun 30, 2026
9.48
Market capitalisation
$2.02B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Most shorted stocks